Tags

Type your tag names separated by a space and hit enter

COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
Vaccine. 2020 11 10; 38(48):7581-7584.V

Abstract

Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those patients requiring intensive care. Here, we illustrate the immunological mechanism to train the immune system towards a more effective and less symptomatic T-helper 1 immune response, to be exploited against SARS-CoV-2.

Authors+Show Affiliations

Institute of Pathology, University Hospital of Modena, Modena, Italy. Electronic address: roncati.luca@aou.mo.it.Department of General Surgery and Surgical Specialties, University of Modena and Reggio Emilia, Modena, Italy; Second Opinion Medical Network, Modena, Italy.Second Opinion Medical Network, Modena, Italy.Department of General Surgery and Surgical Specialties, University of Modena and Reggio Emilia, Modena, Italy; Second Opinion Medical Network, Modena, Italy.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33071005

Citation

Roncati, Luca, et al. "COVID-19 Vaccine and Boosted Immunity: Nothing Ad Interim to Do?" Vaccine, vol. 38, no. 48, 2020, pp. 7581-7584.
Roncati L, Vadalà M, Corazzari V, et al. COVID-19 vaccine and boosted immunity: Nothing ad interim to do? Vaccine. 2020;38(48):7581-7584.
Roncati, L., Vadalà, M., Corazzari, V., & Palmieri, B. (2020). COVID-19 vaccine and boosted immunity: Nothing ad interim to do? Vaccine, 38(48), 7581-7584. https://doi.org/10.1016/j.vaccine.2020.10.013
Roncati L, et al. COVID-19 Vaccine and Boosted Immunity: Nothing Ad Interim to Do. Vaccine. 2020 11 10;38(48):7581-7584. PubMed PMID: 33071005.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 vaccine and boosted immunity: Nothing ad interim to do? AU - Roncati,Luca, AU - Vadalà,Maria, AU - Corazzari,Veronica, AU - Palmieri,Beniamino, Y1 - 2020/10/09/ PY - 2020/04/12/received PY - 2020/08/21/revised PY - 2020/10/05/accepted PY - 2020/10/20/pubmed PY - 2020/11/13/medline PY - 2020/10/19/entrez KW - Bacillus Calmette-Guérin (BCG) KW - Coronavirus Disease 2019 (COVID-19) KW - Corynebacterium parvum (C. parvum) KW - Cutibacterium acnes (C. acnes) KW - Hyaluronic acid KW - Propionibacterium acnes (P. acnes) KW - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) KW - T helper 1 (T(h)1) KW - T helper 2 (T(h)2) KW - Vaccine KW - cluster of differentiation 44 (CD44) SP - 7581 EP - 7584 JF - Vaccine JO - Vaccine VL - 38 IS - 48 N2 - Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those patients requiring intensive care. Here, we illustrate the immunological mechanism to train the immune system towards a more effective and less symptomatic T-helper 1 immune response, to be exploited against SARS-CoV-2. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/33071005/COVID_19_vaccine_and_boosted_immunity:_Nothing_ad_interim_to_do L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(20)31303-7 DB - PRIME DP - Unbound Medicine ER -